Introduction
A keloid is an abnormal overgrowth of scar tissue that develops after the skin has been injured. Unlike a normal scar, which stays within the boundaries of the original wound and gradually softens over time, a keloid extends beyond the area of injury and continues to grow because the wound-healing process becomes overactive. The condition involves the skin, especially the dermis, and reflects a persistent disturbance in the way connective tissue is repaired after trauma.
At a biological level, keloid formation is the result of dysregulated healing. Fibroblasts, the cells that build connective tissue, produce excess collagen and other extracellular matrix components, while signals that normally limit healing remain insufficient or poorly controlled. The result is a dense, raised mass of scar tissue that represents a failure of the skin to complete the normal transition from repair to remodeling.
The Body Structures or Systems Involved
Keloids arise in the skin, specifically from the deeper layer called the dermis. The skin is the body’s outer barrier and is built to resist injury, prevent water loss, and protect internal tissues from infection and physical stress. When the skin is damaged, repair begins immediately through a coordinated sequence of inflammation, tissue formation, and remodeling.
The main cells involved in keloid formation are fibroblasts, which reside in connective tissue and are responsible for making collagen, elastin-associated proteins, and other components of the extracellular matrix. In healthy wound healing, fibroblasts migrate into the injured area, deposit temporary structural material, and then gradually reduce activity as the tissue matures. In a keloid, these cells remain overly active for too long.
Blood vessels, immune cells, and chemical signaling pathways also participate. Macrophages, lymphocytes, mast cells, growth factors, and cytokines all help regulate wound healing. Normally, these signals are tightly balanced so that inflammation resolves and the repair process ends. In keloid-prone tissue, the balance shifts toward persistent stimulation, prolonged matrix production, and incomplete remodeling.
How the Condition Develops
Keloid formation begins after a trigger such as a cut, surgical incision, burn, acne lesion, tattoo, body piercing, or even minor skin trauma. The initial wound activates the body’s standard repair cascade. Platelets form a clot, inflammatory cells move into the site, and fibroblasts begin laying down collagen to close the defect. In ordinary healing, this response slows once the wound is sealed. In keloid formation, the signal to stop is weak or delayed.
The central feature is excessive fibroblast activity. These cells proliferate more than expected and produce large amounts of type I and type III collagen, along with fibronectin, proteoglycans, and other matrix proteins. Instead of forming a thin, organized scar, the tissue becomes thick and densely packed. Collagen fibers are arranged in a disordered pattern, creating a firm, rubbery mass that protrudes above the level of the skin.
Several molecular pathways contribute to this process. Growth factors such as transforming growth factor beta, platelet-derived growth factor, and vascular endothelial growth factor can remain elevated or be overly responsive in keloid tissue. These molecules stimulate fibroblast growth, collagen synthesis, and blood vessel formation. At the same time, normal counter-regulatory mechanisms that would reduce matrix deposition or increase collagen breakdown are less effective.
One important feature is an imbalance between synthesis and degradation of extracellular matrix. Healthy tissue remodeling depends on enzymes called matrix metalloproteinases, which break down excess collagen and help reshape the scar. Their activity is controlled by tissue inhibitors of metalloproteinases. In keloids, the balance favors accumulation rather than removal, so the scar keeps expanding. Some fibroblasts in keloid tissue also show resistance to apoptosis, meaning they do not undergo the normal programmed cell death that helps end the repair response.
The inflammatory phase may also be prolonged. Immune cells can continue to release cytokines that sustain fibroblast activation. This creates a self-reinforcing environment in which inflammation, collagen deposition, and tissue growth support one another. The result is not a tumor in the cancerous sense, but a benign fibroproliferative lesion driven by abnormal wound biology.
Structural or Functional Changes Caused by the Condition
The most obvious structural change is the formation of a scar that rises above the surrounding skin and extends beyond the original wound margins. This growth reflects an expansion of dense connective tissue in the dermis. Under the microscope, keloid tissue contains thick bundles of collagen and abundant fibroblasts. The collagen architecture is less organized than in normal skin, which is one reason the lesion feels firm and irregular.
Functionally, the altered tissue behaves differently from normal skin. The dermis loses some of its usual flexibility because the excess matrix is stiff and compact. The skin over the lesion may also have different mechanical properties, including altered tension and reduced elasticity. Since collagen content and organization affect the physical behavior of skin, a keloid can change how the affected area moves and responds to stretching.
Vascular and inflammatory changes are part of the same process. Keloid tissue can contain increased microvascularity, which supports ongoing growth by supplying oxygen and nutrients. Persistent low-grade inflammation may also be present, reflecting continued immune signaling rather than acute infection. These features help sustain the lesion even after the original wound has closed.
Unlike a normal scar that matures into a relatively stable and flattened structure, keloid tissue remains biologically active. Cells continue to signal, proliferate, and deposit matrix. The lesion is therefore not just a residual mark from an old injury; it is the visible result of a wound-healing program that has failed to shut down properly.
Factors That Influence the Development of the Condition
Several factors affect whether a person develops a keloid after skin injury. Genetic susceptibility is one of the strongest influences. Keloids occur more commonly in some families and certain populations, which suggests inherited differences in wound-healing regulation, fibroblast responsiveness, immune signaling, and collagen metabolism. The exact genes involved are complex and not fully defined, but the pattern indicates a biologic predisposition rather than a random outcome.
Skin injury itself is a major trigger, but the type and location of injury matter. Areas under higher tension, such as the chest, shoulders, upper back, jawline, and earlobes, are more likely to develop keloids. Mechanical tension influences wound biology by altering cell signaling, fibroblast activation, and matrix remodeling. In some cases, the same amount of injury produces an ordinary scar in one region and a keloid in another because local mechanical and cellular conditions differ.
Age and hormonal environment may also play a role, although not in a simple cause-and-effect way. Keloids often develop during periods when skin injury is more common and wound repair activity is robust. The skin’s cellular response to growth factors can vary with age and developmental stage. However, the primary mechanism remains local wound dysregulation rather than a broad hormonal disorder.
Inflammatory burden is another contributing factor. Wounds that heal slowly, become irritated, or experience repeated trauma may maintain signaling pathways that favor scarring. Infection is not required for keloid formation, but prolonged inflammation from any source can amplify fibroblast activation and matrix deposition. The intensity and duration of the initial wound response help shape whether the healing process resolves normally or shifts toward keloid growth.
Variations or Forms of the Condition
Keloids vary in size, shape, and growth pattern. Some remain relatively small and localized, while others enlarge extensively and become thick, lobulated, or irregular. The visible form depends on how strongly fibroblasts are activated, how long the abnormal signaling persists, and how much mechanical tension acts on the area. A small lesion may represent a limited fibroproliferative response, whereas a large lesion suggests prolonged and widespread matrix production.
Some keloids develop from obvious injuries, while others appear after minor trauma that may not seem significant at the time. This difference reflects individual susceptibility rather than a different disease process. The underlying biology is the same, but the threshold for triggering abnormal scarring is lower in susceptible tissue.
Keloids can also differ by body site. Ear keloids, for example, may arise after piercing, while chest or shoulder keloids often follow acne, surgery, or trauma in regions of high tension. Site-specific differences arise because skin thickness, collagen architecture, and mechanical forces are not uniform across the body.
From a biological standpoint, there is a spectrum of behavior. Some lesions are relatively inactive after they form, while others continue to enlarge over time. This variation likely reflects differences in the persistence of growth factor signaling, fibroblast sensitivity, immune activity, and the local environment surrounding the scar.
How the Condition Affects the Body Over Time
Over time, a keloid may remain stable, slowly expand, or enter phases of continued growth and partial quiescence. The long-term behavior depends on how persistent the abnormal wound-healing signals remain. Because the lesion contains living cells and active signaling pathways, it is capable of change long after the original injury has healed.
Chronically, the main physiologic effect is persistent remodeling of connective tissue. Instead of converting into a mature, relatively inactive scar, the lesion stays in a state of ongoing matrix turnover and deposition. This can alter the mechanical properties of the skin and maintain a cycle of local tissue stress. In some cases, repeated irritation or stretching can further stimulate fibroblasts and reinforce the lesion’s growth tendency.
The body generally does not treat the keloid as foreign tissue, so there is no classic rejection response. Instead, the lesion becomes part of the local skin architecture, even though its structure is abnormal. The immune system and fibroblasts continue to interact, but the regulatory balance remains skewed toward scarring rather than resolution. This makes keloids biologically stable yet dynamically active.
Because the lesion is composed of overgrown scar tissue rather than normal dermis, it can also represent a permanent change in tissue organization. The surrounding skin may adapt to the altered tension and stiffness, but the central defect in collagen regulation remains. In this sense, a keloid is best understood as a chronic disorder of scar formation rather than a one-time wound response.
Conclusion
Keloid is an abnormal scar characterized by excessive collagen deposition and persistent fibroblast activity after skin injury. It develops in the dermis when the wound-healing process fails to shut down normally, allowing inflammation, growth factor signaling, and extracellular matrix production to continue beyond the needed repair phase. The result is a raised, dense mass of scar tissue that extends beyond the original wound and remains biologically active.
Understanding keloid formation requires attention to the cells, signals, and mechanical forces that govern skin repair. Fibroblasts, immune mediators, collagen turnover, and tissue tension all contribute to whether a wound heals normally or progresses into a keloid. The condition is therefore not just a visible scar, but a specific example of dysregulated connective tissue remodeling in the skin.